Pylera 140 mg/125 mg/125 mg, Hartkapseln

7680663660013 CH-66366 Kapseln
Pylera 140 mg/125 mg/125 mg, Hartkapseln
Pylera 140 mg/125 mg/125 mg, Hartkapseln
Pylera 140 mg/125 mg/125 mg, Hartkapseln
1 / 3
google

Article details

Package size
120
Selling units
120
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
10/05/2025
Summary of Product Characteristics
Français
10/05/2025
Summary of Product Characteristics
Italien
10/05/2025
Patient information leaflet
Allemand
08/05/2025
Patient information leaflet
Français
08/05/2025
Patient information leaflet
Italien
08/05/2025

Detailed composition

Substance Quantity Type Category
(N/A)
140.0 MG Substance Wirkstoff (Principe actif)
(N/A)
125.0 MG Substance Wirkstoff (Principe actif)
(N/A)
125.0 MG Substance Wirkstoff (Principe actif)
(N/A)
61.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
35.06 MG Substance HBESI

Reimbursement information

Public price
CHF 84.05
Specialties list
Yes
Generic
No
SL addition date: 01/09/2018

Authorization holder

Medius AG

4132 Muttenz

Authorization information

Swissmedic authorization number
66366
Drug name
Pylera, Hartkapseln
Galenic form
KAHA
ATC Code
A02BD08
Authorization status
Z
Dispensing category
A
First authorization
30/11/2017
Authorization expiration date
31/12/9999
IT Number
04.99.0.
Domain
Human medicine
Field of application
Eradikation H.pylori in Kombination mit Omeprazol

Package details

Description (FR)
PYLERA caps 140 mg/125 mg/125 mg bte 120 pce
Description (DE)
PYLERA Kaps 140 mg/125 mg/125 mg Ds 120 Stk
Market launch
30/11/2017
Narcotic (BTM)
No